Should I buy or sell Guardion Health Sciences stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Guardion Health Sciences in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" GHSI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GHSI, but not buy additional shares or sell existing shares. View GHSI analyst ratings or view top-rated stocks .

How have GHSI shares performed in 2024?

Guardion Health Sciences' stock was trading at $5.34 on January 1st, 2024. Since then, GHSI stock has increased by 50.7% and is now trading at $8.05. View the best growth stocks for 2024 here .

Are investors shorting Guardion Health Sciences?

Guardion Health Sciences saw a increase in short interest in March. As of March 31st, there was short interest totaling 139,800 shares, an increase of 14.2% from the March 15th total of 122,400 shares. Based on an average daily volume of 208,600 shares, the days-to-cover ratio is presently 0.7 days. Approximately 13.7% of the company's stock are sold short. View Guardion Health Sciences' Short Interest .

When is Guardion Health Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our GHSI earnings forecast .

How were Guardion Health Sciences' earnings last quarter?

Guardion Health Sciences, Inc. (NASDAQ:GHSI) issued its earnings results on Monday, August, 12th. The company reported ($42.00) EPS for the quarter. The company earned $0.26 million during the quarter. Guardion Health Sciences had a net margin of 0.51% and a trailing twelve-month return on equity of 2.01%.

When did Guardion Health Sciences' stock split?

Guardion Health Sciences shares reverse split on the morning of Sunday, January 8th 2023. The 1-50 reverse split was announced on Sunday, January 8th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, January 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

What other stocks do shareholders of Guardion Health Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Guardion Health Sciences investors own include iBio (IBIO) , Biocept (BIOC) , Onconova Therapeutics (ONTX) , Heat Biologics (HTBX) , VBI Vaccines (VBIV) , Inovio Pharmaceuticals (INO) , Ocugen (OCGN) , Tonix Pharmaceuticals (TNXP) , Co-Diagnostics (CODX) and FuelCell Energy (FCEL) .

When did Guardion Health Sciences IPO?

Guardion Health Sciences (GHSI) raised $6 million in an IPO on Friday, April 5th 2019. The company issued 1,500,000 shares at $4.00 per share. WallachBeth Capital and Westpark Capital acted as the underwriters for the IPO.

How do I buy shares of Guardion Health Sciences?

Shares of GHSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:GHSI

Guardion Health Sciences (GHSI) Stock Price, News & Analysis

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)

Free GHSI Stock Alerts

$8.05

-0.02 (-0.25%)

(As of 04/18/2024 ET)

Compare

Today's Range: $7.96
▼
$8.07
50-Day Range: $7.82
▼
$9.10
52-Week Range: $5.01
▼
$10.75

Volume: 4,092 shs
Average Volume: 184,444 shs
Market Capitalization: $10.30 million

P/E Ratio: 73.19
Dividend Yield: N/A
Price Target: N/A

Get Guardion Health Sciences alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Guardion Health Sciences Stock (NASDAQ:GHSI)

Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported nutrition, medical foods, and dietary supplements in North America and Europe, and Internationally. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.

GHSI Stock Price History

30 days | 90 days | 365 days | Advanced Chart

GHSI Stock News Headlines

April 17, 2024 | morningstar.com

Guardion Health Sciences Inc GHSI

April 15, 2024 | finance.yahoo.com

Guardion Health Sciences, Inc. (GHSI)

April 19, 2024 | InvestorPlace (Ad)

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

April 14, 2024 | americanbankingnews.com

Guardion Health Sciences (GHSI) Set to Announce Quarterly Earnings on Monday

April 9, 2024 | msn.com

Molecular Templates, Acorda Therapeutics, MyMD Pharmaceuticals among healthcare movers

April 4, 2024 | msn.com

Access Bank Ghana makes historic GHS One billion plus profit before tax

April 1, 2024 | finance.yahoo.com

Why Guardion Health Sciences, Inc. (NASDAQ:GHSI) Could Be Worth Watching

March 29, 2024 | markets.businessinsider.com

Guardion Health Swings To Annual Net Profit, Revenue Improves

April 19, 2024 | InvestorPlace (Ad)

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

March 29, 2024 | globenewswire.com

Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023

March 28, 2024 | finance.yahoo.com

GHS Label Market Set to Achieve Steady Growth with a 3.4% CAGR through 2034 | Future Market Insights Inc.

February 24, 2024 | msn.com

Guardion Health Sciences (GHSI) Price Target Increased by 233.33% to 40.80

February 1, 2024 | realmoney.thestreet.com

Maxim gets more bearish on Guardion Health Sciences, downgrades shares

February 1, 2024 | msn.com

Why Guardion Health Sciences Stock Is Up Today

February 1, 2024 | msn.com

Guardion Health Sciences Sells Activ to Doctor’s Best

January 31, 2024 | marketwatch.com

Guardion Health Shares Soar Premarket on Deal to Sell Viactiv

January 31, 2024 | markets.businessinsider.com

Why Is Guardion Health (GHSI) Stock Up 66% Today?

January 30, 2024 | finance.yahoo.com

Guardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv® Brand and Business to Doctor’s Best Inc.

November 22, 2023 | msn.com

Kadjebi GHS exceeds SMC registration, dosing target

November 13, 2023 | finance.yahoo.com

Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2023

November 6, 2023 | msn.com

GHS to launch “ART at 20 celebrations” to showcase impact on lives

August 25, 2023 | markets.businessinsider.com

Maxim Group Sticks to Their Buy Rating for Guardion Health Sciences (GHSI)

August 14, 2023 | finance.yahoo.com

Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2023

July 1, 2023 | finance.yahoo.com

GHSI - Guardion Health Sciences, Inc.

June 28, 2023 | finance.yahoo.com

Guardion Health Sciences Insider Ups Holding By 115% During Year

May 30, 2023 | seekingalpha.com

Guardion Health Sciences appoints president and CEO

May 30, 2023 | finance.yahoo.com

Guardion Health Sciences Announces Appointment of Former Neutrogena and Coca-Cola Executive Jan Hall as President and Chief Executive Officer

See More Headlines

Receive GHSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Guardion Health Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 8/12/2019
Today: 4/18/2024
Next Earnings (Estimated): 5/20/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:GHSI
CUSIP: N/A
CIK: 1642375
Web: www.guardionhealth.com
Phone: (800) 873-5141
Fax: 858-630-5543
Employees: 9
Year Founded: 2009

Profitability

EPS (Most Recent Fiscal Year): $0.11
Trailing P/E Ratio: 73.19
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $160,000.00
Net Margins: 0.51%
Pretax Margin: 1.29%
Return on Equity: 2.01%
Return on Assets: 1.21%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 9.01
Quick Ratio: 6.98

Sales & Book Value

Annual Sales: $12.25 million
Price / Sales: 0.84
Cash Flow: $0.14 per share
Price / Cash Flow: 56.42
Book Value: $6.39 per share
Price / Book: 1.26

Miscellaneous

Outstanding Shares: 1,280,000
Free Float: 1,267,000
Market Cap: $10.30 million
Optionable: Not Optionable
Beta: 0.88

Social Links

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Mr. Robert Neal Weingarten (Age 72)
Independent Chairman & Secretary
Comp: $79k
Mr. Craig J. Sheehan (Age 53)
Chief Commercial Officer
Comp: $256.88k
Ms. Janet Hall (Age 65)
President & CEO
Ms. Katie Cox (Age 54)
Chief Accounting Officer

Key Competitors

View All Competitors

GHSI Stock Analysis - Frequently Asked Questions

Should I buy or sell Guardion Health Sciences stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Guardion Health Sciences in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" GHSI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GHSI, but not buy additional shares or sell existing shares.
View GHSI analyst ratings or view top-rated stocks.
How have GHSI shares performed in 2024?: Guardion Health Sciences' stock was trading at $5.34 on January 1st, 2024. Since then, GHSI stock has increased by 50.7% and is now trading at $8.05.
View the best growth stocks for 2024 here.
Are investors shorting Guardion Health Sciences?: Guardion Health Sciences saw a increase in short interest in March. As of March 31st, there was short interest totaling 139,800 shares, an increase of 14.2% from the March 15th total of 122,400 shares. Based on an average daily volume of 208,600 shares, the days-to-cover ratio is presently 0.7 days. Approximately 13.7% of the company's stock are sold short.
View Guardion Health Sciences' Short Interest.
When is Guardion Health Sciences' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our GHSI earnings forecast.
How were Guardion Health Sciences' earnings last quarter?: Guardion Health Sciences, Inc. (NASDAQ:GHSI) issued its earnings results on Monday, August, 12th. The company reported ($42.00) EPS for the quarter. The company earned $0.26 million during the quarter. Guardion Health Sciences had a net margin of 0.51% and a trailing twelve-month return on equity of 2.01%.

When did Guardion Health Sciences' stock split?: Guardion Health Sciences shares reverse split on the morning of Sunday, January 8th 2023. The 1-50 reverse split was announced on Sunday, January 8th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, January 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.
What other stocks do shareholders of Guardion Health Sciences own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Guardion Health Sciences investors own include iBio (IBIO), Biocept (BIOC), Onconova Therapeutics (ONTX), Heat Biologics (HTBX), VBI Vaccines (VBIV), Inovio Pharmaceuticals (INO), Ocugen (OCGN), Tonix Pharmaceuticals (TNXP), Co-Diagnostics (CODX) and FuelCell Energy (FCEL).
When did Guardion Health Sciences IPO?: Guardion Health Sciences (GHSI) raised $6 million in an IPO on Friday, April 5th 2019. The company issued 1,500,000 shares at $4.00 per share. WallachBeth Capital and Westpark Capital acted as the underwriters for the IPO.
How do I buy shares of Guardion Health Sciences?: Shares of GHSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GHSI) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial